The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Operation Supplement Safety (OPSS) Bethesda MD The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest